Aum Cardiovascular said today that it won 510(k) clearance from the FDA for its Cadence device, which is designed to detect heart murmurs. Cadence works by applying an algorithm to the acoustic signature of heart murmurs in the primary care setting, allowing physicians to diagnose the condition without resorting to expensive CT, MRI or ultrasound […]
The medtech industry is increasingly gaining women leaders. Johnson & Johnson and Medtronic have a handful of women in positions of power, which is a step forward for women considering that only 4% of healthcare CEOs are women. Keeping with the theme of March’s Women’s History Month, here are 13 more women leaders in medtech that we […]
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! More than a decade ago, AUM Cardiovascular founder Dr. Marie Johnson was a doctoral student when tragedy struck her and her family. Her husband, Rob, passed away […]
Aum Cardiovascular today released preliminary results from the pivotal clinical trial of its Cadence heart disease diagnostics device, touting the device’s efficacy at detecting significant obstructive coronary artery disease. Aum’s Cadence is designed to identify obstructions in the coronary arteries by detecting acoustic signals generated by the turbulence created as blood flows past the obstruction, according to the […]
AUM Cardiovascular said last week it completed enrollment for the pivotal study of its CADence handheld heart disease diagnostics device. Aum’s Cadence is designed to identify obstructions in the coronary arteries by detecting acoustic signals generated by the turbulence created as blood flows past the obstruction, according to the company’s site. The company’s name is based on a […]
By Scott Wooldridge Last night’s DeviceTalks: Minnesota event in Minneapolis highlighted the risks and rewards of medical device entrepreneurship, contrasting the arcs of Kips Bay Medical (OTC:KIPS) and Aum Cardiovascular. Kips Bay founder & CEO Manny Villafaña, the medtech legend who started Guidant and St. Jude Medical (NYSE:STJ), told MassDevice.com publisher Brian Johnson that the company’s wind-down was precipitated by a […]
Aum Cardiovascular said in a regulatory filing that it raised $5 million of a hoped-for $6.3 million funding push for the Cadence handheld device it developed to detect heart disease. The Northfield, Minn.-based company was founded by CEO Marie Johnson after the unexpected death of her husband from a heart attack at age 41, according to Aum […]
Steve Kiemele got a taste for what early detection of coronary heart disease means – not at the doctor’s office, but in an attorney’s office in downtown Minneapolis during an investor presentation.
Kiemele, the CFO of the North Dakota life sciences fund Linn Grove Ventures, was in Minneapolis in January to listen to a pitch by Marie Johnson, the founder of AUM Cardiovascular.
The Farmington, Minn.-based company is developing a non-invasive handheld device to assess risk of coronary heart disease.